Amarin posted an updated Investor Presentation for December 2019. The presentation is embedded below: ...
Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre...
Anyone who knows biotech investing has heard of the major hedge funds who invest in the biotechnology and life sciences sectors. Aside from Baker Brothers Advisors, potentially the most famous fund in the space is Perceptive Advisors...
VBI Vaccines posted an updated Corporate Presentation for December 2019...
Axovant Gene Therapies Ltd. (NASDAQ: AXGT) today announced preliminary findings from an expanded access treatment in which a single patient with GM1 gangliosidosis ...
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announces its financial results...
Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S. Food and Drug Administration (FDA)...
Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS)...
Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tucatinib, in combination with trastuzumab and capecitabine...
I’ve always had an interest in investing, buying my first stock at age 16 with a Charles Schwab account that I setup on my own. The company was Manor Care, as this was before the wide use of the internet...